https://www.marketscreener.com/quote/stock/PROTALEX-INC-120787443/news/Protalex-Inc-Announces-Data-from-Phase-1b-Trial-of-PRTX-100-in-Patients-with-Active-Rheumatoid-Arth-38542348/?utm_source=telegram&utm_medium=social&utm_campaign=share